Mechanisms of Deng-Shi-Qing-Mai-Tang in alleviating PM2.5-Induced lung Injury: Network pharmacology, metabolomics, and molecular Target validation
Journal of Ethnopharmacology · 2025
DOI: 10.1016/j.jep.2025.119910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von You Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510000, China; Guangdong…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Particulate Matter, Lung Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: State Key Laboratory of Respiratory Disease, Guangdong Provincial Hospital of Traditional Chinese Medicine, National Natural Science Foundation of China.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Deng-Shi-Qing-Mai-Tang (DSQMT) is a traditional Chinese herbal formula known for treating inflammatory diseases, particularly those affecting respiratory health. Urban air pollution, especially fine particulate matter (PM2.5), induces lung injury primarily through inflammation and oxidative stress. DSQMT's potential to mitigate PM2.5-induced lung damage makes it a promising ethnopharmacological candidate for pollution-related pulmonary disorders. AIM OF THE STUDY: This study aims to uncover the therapeutic mechanisms of DSQMT in alleviating PM2.5-induced lung injury, focusing on identifying its active compounds and their molecular targets. By integrating network pharmacology, metabolomics, and experimental validation, we provide a comprehensive understanding of DSQMT's mode of action. MATERIALS AND METHODS: We established a rat model of PM2.5-induced lung injury and an in vitro model using PM2.5-treated NR8383 cells. Network pharmacology was applied to predict molecular targets and associated biological pathways affected by DSQMT. Metabolomic profiling identified key metabolic changes, and a pharmacological-metabolomic network was constructed. Molecular docking assessed by binding affinities between DSQMT's active compounds and their targets. The therapeutic effects of DSQMT were evaluated using histological analysis, cytotoxicity assays, and oxidative stress markers, including reactive oxygen species (ROS), malondialdehyde (MDA), and superoxide dismutase (SOD). Additionally, the roles of Rutin and Morusin, two bioactive compounds, were further validated through RT-qPCR and Western blot to determine their effects on NOS2 and ALOX15 expression. RESULTS: DSQMT treatment reversed PM2.5-induced metabolic disturbances, restoring homeostasis in key pathways. We identified fifty-one therapeutic targets and fifty metabolites, with NOS2 and ALOX15 emerging as central to DSQMT's protective effects. Molecular docking revealed strong binding between Morusin and NOS2, as well as Rutin and ALOX15. In vitro experiments showed that DSQMT reduced oxidative stress and cytotoxicity, as evidenced by decreased ROS and MDA levels and increased SOD activity. RT-qPCR and Western blot confirmed that Rutin and Morusin modulated NOS2 and ALOX15 expression, validating their contributions to DSQMT's anti-inflammatory and antioxidant effects. CONCLUSIONS: DSQMT alleviates PM2.5-induced lung injury through metabolic regulation and antioxidant activity. The identification of Rutin and Morusin as key compounds targeting NOS2 and ALOX15 provides mechanistic insights into DSQMT's therapeutic effects. These findings support DSQMT as a potential treatment for PM2.5-related lung injury, highlighting its relevance in managing pollution-induced respiratory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510000, China; Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, 510000, Ch…
- Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510000, China. Electronic address: 20231110777@stu.gzucm.edu.cn.
- Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510000, China. Electronic address: 20241110875@stu.gzucm.edu.cn.
- Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510000, China. Electronic address: 20228120140@stu.gzucm.edu.cn.
- Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510000, China. Electronic address: 20221120881@stu.gzucm.edu.cn.
- Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510000, China. Electronic address: 2018022038@stu.gzucm.edu.cn.
Förderung
- State Key Laboratory of Respiratory Disease
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- National Natural Science Foundation of China
- Guangzhou Municipal Science and Technology Project
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Zhou, Y., Wen, C., Huang, Y., Xu, J., Li, H., Chen, X., Zeng, Y., Huang, H., & Xu, Y. (2025). Mechanisms of Deng-Shi-Qing-Mai-Tang in alleviating PM2.5-Induced lung Injury: Network pharmacology, metabolomics, and molecular Target validation. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119910
Vancouver
Zhou Y, Wen C, Huang Y, Xu J, Li H, Chen X, et al. Mechanisms of Deng-Shi-Qing-Mai-Tang in alleviating PM2.5-Induced lung Injury: Network pharmacology, metabolomics, and molecular Target validation. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119910
BibTeX
@article{Zhou2025,
author = {Zhou, You and Wen, Chaowei and Huang, Yinjun and Xu, Junhao and Li, Haipeng and Chen, Xinming and Zeng, Yanxia and Huang, Hongzhi and Xu, Yinji},
title = {Mechanisms of Deng-Shi-Qing-Mai-Tang in alleviating PM2.5-Induced lung Injury: Network pharmacology, metabolomics, and molecular Target validation},
journal = {Journal of Ethnopharmacology},
year = {2025},
doi = {10.1016/j.jep.2025.119910}
}
EUVIMED